Possibility of checking compliance and efficacy of antiaggregatory treatment following femoro-popliteal vein bypass surgery.
Salat
A
A
Department of Surgery, University of Vienna, Austria.
Boehm
D
D
Pulaki
S
S
Murabito
M
M
Berlakovich
G
G
Kretschmer
G
G
Mueller
M R
MR
D000714:Anastomosis, Surgical; D001162:Arteriosclerosis Obliterans / Q000601:surgery; D001241:Aspirin / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects; D005260:Female; D005268:Femoral Vein / Q000637:transplantation*; D005500:Follow-Up Studies; D006801:Humans; D007866:Leg / Q000098:blood supply; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011152:Popliteal Vein / Q000637:transplantation*; D011183:Postoperative Complications / Q000517:prevention & control; D013927:Thrombosis / Q000097:blood / Q000517:prevention & control*; D016896:Treatment Outcome
D010975:Platelet Aggregation Inhibitors; D001241:Aspirin